BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35042132)

  • 21. The role of new imaging techniques in diagnosis and staging of malignant pleural mesothelioma.
    Eibel R; Tuengerthal S; Schoenberg SO
    Curr Opin Oncol; 2003 Mar; 15(2):131-8. PubMed ID: 12601277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.
    Rusch VW
    Lung Cancer; 1996 Feb; 14(1):1-12. PubMed ID: 8696713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical assessment of malignant pleural mesothelioma: have we reached a critical stage?
    Nakas A; Black E; Entwisle J; Muller S; Waller DA
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1457-63. PubMed ID: 20138534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The highlights of the 15th international conference of the international mesothelioma interest group - Do molecular concepts challenge the traditional approach to pathological mesothelioma diagnosis?
    Klebe S; Galateau Salle F; Bruno R; Brcic L; I Chen-Yost H; Jaurand MC
    Lung Cancer; 2022 Jan; 163():1-6. PubMed ID: 34864334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study.
    Botticella A; Defraene G; Nackaerts K; Deroose CM; Coolen J; Nafteux P; Peeters S; Ricardi U; De Ruysscher D
    Acta Oncol; 2016 Dec; 55(12):1450-1455. PubMed ID: 27732127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomography in the evaluation of malignant pleural mesothelioma-Association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival.
    Paajanen J; Laaksonen S; Ilonen I; Wolff H; Husgafvel-Pursiainen K; Kuosma E; Ollila H; Myllärniemi M; Vehmas T
    Lung Cancer; 2018 Feb; 116():73-79. PubMed ID: 29413055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1).
    Armato SG; Nowak AK
    J Thorac Oncol; 2018 Jul; 13(7):1012-1021. PubMed ID: 29753121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.
    Wang ZJ; Reddy GP; Gotway MB; Higgins CB; Jablons DM; Ramaswamy M; Hawkins RA; Webb WR
    Radiographics; 2004; 24(1):105-19. PubMed ID: 14730040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging.
    Patz EF; Rusch VW; Heelan R
    AJR Am J Roentgenol; 1996 Feb; 166(2):323-7. PubMed ID: 8553940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study.
    Gill RR; Naidich DP; Mitchell A; Ginsberg M; Erasmus J; Armato SG; Straus C; Katz S; Patios D; Richards WG; Rusch VW;
    J Thorac Oncol; 2016 Aug; 11(8):1335-1344. PubMed ID: 27180318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.
    Heelan RT; Rusch VW; Begg CB; Panicek DM; Caravelli JF; Eisen C
    AJR Am J Roentgenol; 1999 Apr; 172(4):1039-47. PubMed ID: 10587144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?
    Pinelli V; Roca E; Lucchini S; Laroumagne S; Loundou A; Dutau H; Maldonado F; Astoul P
    Respiration; 2015; 89(6):558-64. PubMed ID: 25966972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation.
    Pass H; Giroux D; Kennedy C; Ruffini E; Cangir AK; Rice D; Asamura H; Waller D; Edwards J; Weder W; Hoffmann H; van Meerbeeck JP; Nowak A; Rusch VW;
    J Thorac Oncol; 2016 Dec; 11(12):2082-2088. PubMed ID: 27670823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging of mesothelioma.
    Gill RR
    Recent Results Cancer Res; 2011; 189():27-43. PubMed ID: 21479894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current trends in radiologic management of malignant pleural mesothelioma.
    Gill RR; Gerbaudo VH; Sugarbaker DJ; Hatabu H
    Semin Thorac Cardiovasc Surg; 2009; 21(2):111-20. PubMed ID: 19822282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New applications of magnetic resonance imaging for thoracic oncology.
    Ohno Y
    Semin Respir Crit Care Med; 2014 Feb; 35(1):27-40. PubMed ID: 24481757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of malignant pleural mesothelioma.
    West SD; Lee YC
    Clin Chest Med; 2006 Jun; 27(2):335-54. PubMed ID: 16716822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the clinical TNM staging system for malignant pleural mesothelioma: an assessment in 88 patients.
    Tammilehto L; Kivisaari L; Salminen US; Maasilta P; Mattson K
    Lung Cancer; 1995 Mar; 12(1-2):25-34. PubMed ID: 7600028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes.
    Gill RR; Umeoka S; Mamata H; Tilleman TR; Stanwell P; Woodhams R; Padera RF; Sugarbaker DJ; Hatabu H
    AJR Am J Roentgenol; 2010 Aug; 195(2):W125-30. PubMed ID: 20651171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.